Olodaterol Oral Inhalation

Major

Olodaterol Oral Inhalation Itraconazole Sporanox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ivabradine Corlanor An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ivosidenib Tibsovo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ketoconazole Extina An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Labetalol Normodyne® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Lapatinib Tykerb An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Lefamulin Xenleta An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Lenvatinib Lenvima An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Leuprolide Eligard An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Levalbuterol Xopenex An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Levobunolol Betagan Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Levofloxacin Levaquin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Linezolid Zyvox Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Lisdexamfetamine Arynta An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Lofepramine Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Lofexidine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Loperamide Diamode An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Lumefantrine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Macimorelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mavorixafor Xolremdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mefloquine Lariam® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Melitracen Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Methacholine Inhibition of the airway response to methacholine Details Olodaterol Oral Inhalation Methadone Diskets An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Methamphetamine Desoxyn An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Methotrimeprazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Methylene Blue Provayblue Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Methylphenidate Adhansia XR® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Metipranolol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Metoprolol Kapspargo Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Metronidazole Flagyl An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Midodrine Orvaten® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Mifepristone Korlym An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mirtazapine Mirataz An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mizolastine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mobocertinib Exkivity An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Modafinil Provigil An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Moricizine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Moxifloxacin Avelox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nadolol Corgard Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details